phase II glucuronidation UGT
Selected indexed studies
- Prediction of UGT-mediated phase II metabolism via ligand- and structure-based predictive models. (J Cheminform, 2025) [PMID:41094537]
- Drug-drug interactions of plant alkaloids derived from herbal medicines on the phase II UGT enzymes: an introductory review. (Naunyn Schmiedebergs Arch Pharmacol, 2025) [PMID:39325152]
- Identification of phase-I and phase-II metabolites and the metabolic pathway of the novel synthetic cannabinoid 5F-EDMB-PICA in vitro. (Arch Toxicol, 2024) [PMID:38955863]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Prediction of UGT-mediated phase II metabolism via ligand- and structure-based predictive models. (2025) pubmed
- Drug-drug interactions of plant alkaloids derived from herbal medicines on the phase II UGT enzymes: an introductory review. (2025) pubmed
- Identification of phase-I and phase-II metabolites and the metabolic pathway of the novel synthetic cannabinoid 5F-EDMB-PICA in vitro. (2024) pubmed
- Glucuronidation and UGT isozymes in bladder: new targets for the treatment of uroepithelial carcinomas? (2017) pubmed
- Epigenetics and microRNAs in UGT1As. (2021) pubmed
- Regulation of phase I and phase II neurosteroid enzymes in the hippocampus of an Alzheimer's disease rat model: A focus on sulphotransferases and UDP-glucuronosyltransferases. (2022) pubmed
- Resolvins D5 and D1 undergo phase II metabolism by uridine 5'-diphospho-glucuronosyltransferases. (2024) pubmed
- Inhibition of aflatoxins on UDP-glucuronosyltransferases (UGTs). (2023) pubmed
- Drug glucuronidation in clinical psychopharmacology. (2001) pubmed
- Glucuronidation: driving factors and their impact on glucuronide disposition. (2017) pubmed